These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 39430818)
1. BUB1 as a novel marker for predicting the immunotherapy efficacy and prognosis of breast cancer. Zhou R; Liu M; Li M; Peng Y; Zhang X Transl Cancer Res; 2024 Sep; 13(9):4534-4554. PubMed ID: 39430818 [TBL] [Abstract][Full Text] [Related]
2. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics]. Li X; He J; Yu M; Zhang W; Sun J Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212 [TBL] [Abstract][Full Text] [Related]
3. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer. Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295 [TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
5. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer. Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062 [TBL] [Abstract][Full Text] [Related]
6. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer. Li D; Zhao W; Zhang X; Lv H; Li C; Sun L Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208 [TBL] [Abstract][Full Text] [Related]
7. Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer. Zhang H; Li Y; Lu H Sci Rep; 2024 Jul; 14(1):17084. PubMed ID: 39048649 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers. Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825 [TBL] [Abstract][Full Text] [Related]
9. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma. Xiao X; Shan H; Niu Y; Wang P; Li D; Zhang Y; Wang J; Wu Y; Jiang H Front Mol Biosci; 2022; 9():647826. PubMed ID: 35558557 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer. He L; Lin Y; Huang P; Pan H Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518152 [TBL] [Abstract][Full Text] [Related]
11. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer]. Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766 [No Abstract] [Full Text] [Related]
12. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients. He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189 [TBL] [Abstract][Full Text] [Related]
13. TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy. Zhu X; Yuan Z; Cheng S; Wang H; Liao Y; Zhou D; Wu Z World J Surg Oncol; 2022 Oct; 20(1):336. PubMed ID: 36207751 [TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer. Han B; Zhen F; Zheng XS; Hu J; Chen XS BMC Cancer; 2022 Mar; 22(1):297. PubMed ID: 35313846 [TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration. Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330 [No Abstract] [Full Text] [Related]
16. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer. Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301 [TBL] [Abstract][Full Text] [Related]
17. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers. Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455 [TBL] [Abstract][Full Text] [Related]
18. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer. Zhang XX; Luo JH; Wu LQ Front Genet; 2022; 13():913659. PubMed ID: 36035176 [No Abstract] [Full Text] [Related]
19. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer. Lin T; Qiu Y; Peng W; Peng L Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341 [TBL] [Abstract][Full Text] [Related]
20. HTRA1 expression is associated with immune-cell infiltration and survival in breast cancer. Zhao D; Li W; Wang Y; Zhang G; Bai X; Yu H Transl Cancer Res; 2023 Dec; 12(12):3503-3521. PubMed ID: 38197075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]